Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darrell E White

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Ophthalmology and Therapy|January 8, 2025
Differentiating Between Perfluorohexyloctane Ophthalmic Solution and Water-Free Cyclosporine Ophthalmic Solution 0.1% for Dry Eye Disease: A Review of Preclinical and Clinical CharacteristicsLaura M Periman, Darrell E White, Douglas Katsev
Obesity Research & Clinical Practice|December 2, 2014
The influence of plaintiff's body weight on judgments of responsibility: the role of weight biasDarrell E White, Carissa B Wott, Robert A Carels
Clinical Ophthalmology (Auckland, N.Z.)|April 8, 2020
Treatment Satisfaction Among Patients Using Anti-Inflammatory Topical Medications for Dry Eye DiseaseDarrell E White, Yang Zhao, Hemalatha Jayapalan, et al.
Clinical Ophthalmology (Auckland, N.Z.)|April 11, 2020
Physician Satisfaction with Anti-Inflammatory Topical Medications for the Treatment of Dry Eye DiseaseDarrell E White, Yang Zhao, Hemalatha Jayapalan, et al.
Eye & Contact Lens|February 7, 2019
Chronic Conjunctivitis From a Retained Contact LensJawad I Arshad, Asma Saud, Darrell E White, et al.
Journal of Managed Care & Specialty Pharmacy|August 28, 2022
Matching-adjusted indirect comparison of phase 3 clinical trial outcomes of OC-01 (varenicline solution) nasal spray and lifitegrast 5% ophthalmic solution for the treatment of dry eye diseaseDarrell E White, Laura H Hendrix, Lucille Sun, et al.
Ophthalmology and Therapy|September 19, 2025
Clinical Benefits of Preservative-Free Treatment for Glaucoma with a Focus on Preservative-Free LatanoprostDeepinder K Dhaliwal, Aakriti Garg Shukla, I Paul Singh, et al.
Clinical Ophthalmology (Auckland, N.Z.)|December 11, 2019
Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry EyeDarrell E White, Yang Zhao, Abayomi Ogundele, et al.
American Journal of Obstetrics and Gynecology|April 11, 2021
Medical and mental health implications of gestational surrogacyAnnie Yau, Rachel L Friedlander, Allison Petrini, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 20, 2019
Safety and efficacy of amniotic cytokine extract in the treatment of dry eye diseaseElizabeth Yeu, Damien F Goldberg, Francis S Mah, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Ophthalmology and Therapy|January 8, 2025
Differentiating Between Perfluorohexyloctane Ophthalmic Solution and Water-Free Cyclosporine Ophthalmic Solution 0.1% for Dry Eye Disease: A Review of Preclinical and Clinical CharacteristicsLaura M Periman, Darrell E White, Douglas Katsev
Obesity Research & Clinical Practice|December 2, 2014
The influence of plaintiff's body weight on judgments of responsibility: the role of weight biasDarrell E White, Carissa B Wott, Robert A Carels
Clinical Ophthalmology (Auckland, N.Z.)|April 8, 2020
Treatment Satisfaction Among Patients Using Anti-Inflammatory Topical Medications for Dry Eye DiseaseDarrell E White, Yang Zhao, Hemalatha Jayapalan, et al.
Clinical Ophthalmology (Auckland, N.Z.)|April 11, 2020
Physician Satisfaction with Anti-Inflammatory Topical Medications for the Treatment of Dry Eye DiseaseDarrell E White, Yang Zhao, Hemalatha Jayapalan, et al.
Eye & Contact Lens|February 7, 2019
Chronic Conjunctivitis From a Retained Contact LensJawad I Arshad, Asma Saud, Darrell E White, et al.
Journal of Managed Care & Specialty Pharmacy|August 28, 2022
Matching-adjusted indirect comparison of phase 3 clinical trial outcomes of OC-01 (varenicline solution) nasal spray and lifitegrast 5% ophthalmic solution for the treatment of dry eye diseaseDarrell E White, Laura H Hendrix, Lucille Sun, et al.
Ophthalmology and Therapy|September 19, 2025
Clinical Benefits of Preservative-Free Treatment for Glaucoma with a Focus on Preservative-Free LatanoprostDeepinder K Dhaliwal, Aakriti Garg Shukla, I Paul Singh, et al.
Clinical Ophthalmology (Auckland, N.Z.)|December 11, 2019
Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry EyeDarrell E White, Yang Zhao, Abayomi Ogundele, et al.
American Journal of Obstetrics and Gynecology|April 11, 2021
Medical and mental health implications of gestational surrogacyAnnie Yau, Rachel L Friedlander, Allison Petrini, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 20, 2019
Safety and efficacy of amniotic cytokine extract in the treatment of dry eye diseaseElizabeth Yeu, Damien F Goldberg, Francis S Mah, et al.
Pageof 2